Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clever Bioscience develops innovative bioactive products—primarily peptides and secondary metabolites—for pharmaceutical applications such as anti-infectives. The company leverages advanced fermentation techniques to produce these actives at scale. Their offerings are used in the treatment of infections like vaginosis, respiratory tract infections, and skin disorders. They also provide contract research/manufacturing services across agrochemical, cosmetic, nutraceutical, and pharma sectors. No proprietary clinical trial results are reported.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clever Bioscience.